GlassScriptPhysician profile
Lisa Dao
NPI 1114422730
$1,911.78
in general payments reported to CMS, 2019-2025
33 companies · $897 in 2025
The $897 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $324 · 2024: $690 · 2025: $897.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,912.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,911.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $192.06 | 2023-2025 | |
| Novo Nordisk INC | $144.03 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Abbott Laboratories | $128.06 | 2024-2025 | Freestyle Libre 3 |
| Amgen INC. | $115.83 | 2023-2025 | Repatha, Evenity, Prolia |
| Sanofi-Aventis U.S. LLC | $107.73 | 2024-2025 | |
| Insulet Corporation | $94.36 | 2023-2025 | Omnipod |
| Lilly USA, LLC | $92.70 | 2023-2025 | Jardiance, Mounjaro, Zepbound |
| Kyowa Kirin, INC. | $88.17 | 2023-2025 | |
| Recordati_rare_diseases_inc. | $69.62 | 2023-2024 | Signifor Lar, Isturisa |
| Abbvie INC. | $65.95 | 2023-2025 | Ubrelvy, Synthroid |
| Madrigal Pharmaceuticals | $62.76 | 2025 | Rezdiffra |
| Dexcom, INC. | $61.68 | 2024-2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.99 | 2023-2025 | Jardiance |
| Radius Health, INC. | $53.57 | 2025 | Tymlos |
| Tandem Diabetes Care, INC. | $48.97 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $48.09 | 2024 | Strensiq |
| Bayer Healthcare Pharmaceuticals INC. | $46.38 | 2025 | |
| Xeris Pharmaceuticals, INC. | $43.95 | 2023-2025 | Recorlev, Gvoke Hypopen |
| Verity Pharmaceuticals INC. | $43.70 | 2025 | Tlando |
| Regeneron Healthcare Solutions, INC. | $36.37 | 2025 | Evkeeza |
| Glaxosmithkline, LLC. | $34.88 | 2024-2025 | Arexvy, Shingrix |
| Cequr Corporation | $33.08 | 2023-2024 | Cequr Simplicity |
| Medtronic, INC. | $31.71 | 2024 | Intellis Adaptivestim |
| Corcept Therapeutics | $27.48 | 2025 | Korlym |
| Ascendis Pharma Endocrinology INC | $26.48 | 2025 | Yorvipath |
| Chiesi USA, INC. | $25.33 | 2025 | Myalept |
| Averitas Pharma INC. | $24.94 | 2025 | Qutenza |
| Halozyme INC | $22.42 | 2023 | |
| Sequel Med Tech, LLC | $20.34 | 2025 | Twiist |
| Ionis Pharmaceuticals, INC. | $19.95 | 2025 | Tryngolza |
| Mannkind Corporation | $17.52 | 2024 | |
| Tolmar, INC. | $16.22 | 2024 | |
| Currax Pharmaceuticals LLC | $13.46 | 2024 | Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Dao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.